471 related articles for article (PubMed ID: 14571795)
1. Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma.
Yeh JL; Peng YC; Tung CF; Yang DY; Hu WH; Chow WK; Yeh HZ; Chen GH
Hepatogastroenterology; 2003; 50(53):1603-8. PubMed ID: 14571795
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease.
Zaman A; Hapke R; Flora K; Rosen HR; Benner K
Am J Gastroenterol; 1999 Nov; 94(11):3292-6. PubMed ID: 10566732
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma.
Giannini EG; Risso D; Testa R; Trevisani F; Di Nolfo MA; Del Poggio P; Benvegnù L; Ludovico Rapaccini G; Farinati F; Zoli M; Borzio F; Caturelli E;
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1378-84. PubMed ID: 17059899
[TBL] [Abstract][Full Text] [Related]
4. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].
Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ
Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic effect of cyanoacrylate on gastric variceal bleeding and factors related to clinical outcome.
Paik CN; Kim SW; Lee IS; Park JM; Cho YK; Choi MG; Chung IS
J Clin Gastroenterol; 2008 Sep; 42(8):916-22. PubMed ID: 18645533
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for esophageal variceal bleeding in patients with hepatocellular carcinoma.
Akanuma M; Yoshida H; Okamoto M; Ogura K; Maeda S; Hata Y; Sato S; Shiina S; Kawabe T; Shiratori Y; Omata M
Hepatogastroenterology; 2002; 49(46):1039-44. PubMed ID: 12143197
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome.
Fagundes ED; Ferreira AR; Roquete ML; Penna FJ; Goulart EM; Figueiredo Filho PP; Bittencourt PF; Carvalho SD; Albuquerque W
J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):178-83. PubMed ID: 18223377
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices.
Park DK; Um SH; Lee JW; Lee JB; Kim YS; Park CH; Jin YT; Chun HJ; Lee HS; Lee SW; Choi JH; Kim CD; Ryu HS; Hyun JH
J Gastroenterol Hepatol; 2004 Sep; 19(9):1042-51. PubMed ID: 15304123
[TBL] [Abstract][Full Text] [Related]
9. Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis.
Han ML; Chen CC; Kuo SH; Hsu WF; Liou JM; Wu MS; Wang HP
J Gastroenterol Hepatol; 2014 Feb; 29(2):344-51. PubMed ID: 23870023
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding.
Lang BH; Poon RT; Fan ST; Wong J
Am J Gastroenterol; 2004 Nov; 99(11):2158-65. PubMed ID: 15554997
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis.
Levy C; Zein CO; Gomez J; Soldevila-Pico C; Firpi R; Morelli G; Nelson D
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):803-8. PubMed ID: 17544879
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients.
Hori S; Takaki A; Okada H; Fujiwara A; Takenaka R; Makidono C; Shiratori Y
J Gastroenterol Hepatol; 2006 Nov; 21(11):1704-9. PubMed ID: 16984593
[TBL] [Abstract][Full Text] [Related]
13. MELD score, child-pugh score, and decreased albumin as risk factors for gastric variceal bleeding.
Soga K; Tomikashi K; Miyawaki K; Fukumoto K; Wakabayashi N; Konishi H; Mitsufuji S; Yoshida N; Kokura S; Naito Y; Kataoka K; Yoshikawa T
Hepatogastroenterology; 2009; 56(94-95):1552-6. PubMed ID: 19950829
[TBL] [Abstract][Full Text] [Related]
14. What are the risk factors for aggravation of esophageal varices in patients with hepatocellular carcinoma?
Kadouchi K; Higuchi K; Shiba M; Okazaki H; Yamamori K; Sasaki E; Tominaga K; Watanabe T; Fujiwara Y; Oshitani N; Arakawa T
J Gastroenterol Hepatol; 2007 Feb; 22(2):240-6. PubMed ID: 17295878
[TBL] [Abstract][Full Text] [Related]
15. Prevention of variceal recurrence, bleeding, and death in cirrhosis patients with hypersplenism, especially those with severe thrombocytopenia.
Ohmoto K; Yamamoto S
Hepatogastroenterology; 2003; 50(54):1766-9. PubMed ID: 14696400
[TBL] [Abstract][Full Text] [Related]
16. Why do varices bleed?
de Franchis R; Primignani M
Gastroenterol Clin North Am; 1992 Mar; 21(1):85-101. PubMed ID: 1568779
[TBL] [Abstract][Full Text] [Related]
17. Bleeding index after the first course of endoscopic treatment for esophageal varices in liver cirrhotic patients with and without hepatocellular carcinoma.
Kogo M; Sato N; Yoneyama K; Imawari M; Kiuchi Y
Hepatogastroenterology; 2007; 54(79):2049-54. PubMed ID: 18251158
[TBL] [Abstract][Full Text] [Related]
18. Injection sclerotherapy for variceal bleeding in patients with irresectable hepatocellular carcinoma.
Letier MH; Krige JE; Lemmer ER; Terblanche J
Hepatogastroenterology; 2000; 47(36):1680-4. PubMed ID: 11149031
[TBL] [Abstract][Full Text] [Related]
19. A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease.
Tacke F; Fiedler K; Trautwein C
Scand J Gastroenterol; 2007 Mar; 42(3):374-82. PubMed ID: 17354118
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study.
Spaander MC; Darwish Murad S; van Buuren HR; Hansen BE; Kuipers EJ; Janssen HL
Gastrointest Endosc; 2008 May; 67(6):821-7. PubMed ID: 18206153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
